참고문헌
- Abdelsalam KE, Hassan IK, Sadig IA (2012). The role of developing breast cancer in alteration of serum lipid profile. J Res Med Sci, 17, 562-5.
- Auguet T, Quintero Y, Terra X, et al (2011). . Obesity, 19, 2295-300Upregulation of lipocalin 2 in adipose tissues of severely obese women: positive relationship with proinflammatory cytokines. https://doi.org/10.1038/oby.2011.61
- Barton BE, Murphy TF (2001). Cancer cachexia is mediated in part by the induction of IL-6-like cytokines from the spleen. Cytokine, 16, 251-7. https://doi.org/10.1006/cyto.2001.0968
- Bauer M, Eickhoff JC, Gould MN, et al (2008). Neutrophil gelatinase-associated lipocalin (NGAL) is a predictor of poor prognosis in human primary breast cancer. Breast Cancer Res Treat, 108, 389-97. https://doi.org/10.1007/s10549-007-9619-3
- Cejas P, Casado E, Belda-Iniesta C, et al (2004). Implications of oxidative stress and cell membrane lipid peroxidation in human cancer (Spain). Cancer Causes Control, 15, 707-19. https://doi.org/10.1023/B:CACO.0000036189.61607.52
- Cramer EP, Glenthoj A, Hager M, et al (2012). No effect of NGAL/lipocalin-2 on aggressiveness of cancer in the MMTV-PyMT/FVB/N mouse model for breast cancer. PLoS One, 7, 39646-59. https://doi.org/10.1371/journal.pone.0039646
- Dandona P, Aljada A, Bandyopadhyay A, et al (2004). Inflammation: The link between insulin resistance, obesity and diabetes. Trends Immunol, 25, 4-7. https://doi.org/10.1016/j.it.2003.10.013
- Derin D, Soydinc HO, Guney N, et al (2007). Serum IL-8 and IL-12 levels in breast cancer. Med Oncol, 24, 163-8. https://doi.org/10.1007/BF02698035
- Drosos Y, Kouloukoussa M, Ostvold AC, et al (2009). NUCKS overexpression in breast cancer. Cancer Cell Int, 9, 19-33 https://doi.org/10.1186/1475-2867-9-19
- Duseja A, Thumburu KK, Das A, et al (2007). Insulin tolerance test is comparable to homeostasis model assessment for insulin resistance in patients with nonalcoholic fatty liver disease. Indian J Gastroenterol, 26, 170-3.
- El-Kadre LJ, Tinoco AC (2013). Interleukin-6 and obesity: the crosstalk between intestine, pancreas and liver. Curr Opin Clin Nutr Metab Care, 16, 564-8.
- Fernandez SV, Robertson FM, Pei J, et al (2013). Inflammatory breast cancer (IBC): clues for targeted therapies. Breast Cancer Res Treat, 140, 23-33. https://doi.org/10.1007/s10549-013-2600-4
- Friedewald WT, Levy RI, Fredrickson DS (1972). Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem, 18, 499-502.
- Gaudet MM, Patel AV, Teras LR, et al (2013). Obesity-related markers and breast cancer in CPS-II Nutrition Cohort. Int J Mol Epidemiol Genet, 4, 156-66.
- Giri D, Ozen M, Ittmann M (2001). Interleukin-6 is an autocrine growth factor in human prostate cancer. Am J Pathol, 159, 2159-65. https://doi.org/10.1016/S0002-9440(10)63067-2
- Gonullu G, Ersoy C, Ersoy A, et al (2005). Relation between insulin resistance and serum concentrations of IL-6 and TNF-alpha in overweight or obese women with early stage breast cancer. Cytokine, 31, 264-9. https://doi.org/10.1016/j.cyto.2005.05.003
- Goodwin PJ, Ennis M, Pritchard KI, et al (2002). Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. J Clin Oncol, 20, 42-51. https://doi.org/10.1200/JCO.20.1.42
- Gorgoulis VG, Vassiliou LV, Karakaidos P, et al (2005). Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature, 434, 907-13. https://doi.org/10.1038/nature03485
-
Goyal R, Faizy AF, Siddiqui SS, Singhai M (2012). Evaluation of TNF-
$\alpha$ and IL-6 levels in obese and non-obese diabetics: Pre- and postinsulin effects. N Am J Med Sci, 4, 180-4. https://doi.org/10.4103/1947-2714.94944 - Grundt K, Haga IV, Aleporou-Marinou V, et al (2004). Characterisation of the NUCKS gene on human chromosome 1q32.1 and the presence of a homologous gene in different species. Biochem Biophys Res Commun, 323, 796-801. https://doi.org/10.1016/j.bbrc.2004.08.153
- Haura EB, Turkson J, Jove R (2005). Mechanisms of disease: insights into the emerging role of signal transducers and activators of transcription in cancer. Nat Clin Pract Oncol, 2, 315-24. https://doi.org/10.1038/ncponc0195
- Hsu IR, Kim SP, Kabir M, et al (2007). Metabolic syndrome, hyperinsulinemia, and cancer. Am J Clin Nutr, 86, 867-71
- Huffman DM, Barzilai N (2009). Role of visceral adipose tissue in aging. Biochim Biophys Acta, 1790, 1117-23. https://doi.org/10.1016/j.bbagen.2009.01.008
- Hussein MZ, Al Fikky A, Abdel Bar I, et al (2004). Serum IL-6 and IL-12 levels in breast cancer patients. Egypt J Immunol, 11, 165-70.
- Jones C, Mackay A, Grigoriadis A, et al (2004). Expression profiling of purified normal human luminal and myoepithelial breast cells: Identification of novel prognostic markers for breast cancer. Cancer Res, 64, 3037-45. https://doi.org/10.1158/0008-5472.CAN-03-2028
- Kedzierska M, Olas B, Wachowicz B, et al (2010). The lipid peroxidation in breast cancer patients. Gen Physiol Biophys, 29, 208-10.
- Law IK, Xu A, Lam KS, et al (2010). Lipocalin-2 deficiency attenuates insulin resistance associated with aging and obesity. Diabetes, 59, 872-82. https://doi.org/10.2337/db09-1541
- Ligibel J (2011). Obesity and breast cancer. Oncology (Williston Park), 25, 994-1000.
- Liu R, Wang X, Chen GY, et al (2007). The Prognostic Role of a Gene Signature from Tumorigenic Breast-Cancer Cells. N Engl J Med, 356, 217-26. https://doi.org/10.1056/NEJMoa063994
- Liu X, Hamnvik OP, Petrou M, et al (2011). Circulating lipocalin 2 is associated with body fat distribution at baseline but is not an independent predictor of insulin resistance: the prospective Cyprus Metabolism Study. Eur J Endocrinol, 165, 805-12. https://doi.org/10.1530/EJE-11-0660
- Matsuoka S, Ballif BA, Smogorzewska A, et al (2007). ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science, 316, 1138-9. https://doi.org/10.1126/science.1143700
- Minamino T, Yoshida T, Tateno K, et al (2003). Ras induces vascular smooth muscle cell senescence and inflammation in human atherosclerosis. Circulation, 108, 2264-9. https://doi.org/10.1161/01.CIR.0000093274.82929.22
- Moschos SJ, Mantzoros CS (2002). The role of the IGF system in cancer: from basic to clinical studies and clinical applications. Oncology, 63, 317-32. https://doi.org/10.1159/000066230
- Naylor TL, Greshock J, Wang Y, et al (2005). High resolution genomic analysis of sporadic breast cancer using arraybased comparative genomic hybridization. Breast Cancer Res, 7, 1186-98. https://doi.org/10.1186/bcr1356
- Nguyen DX, Massague J (2007). Genetic determinants of cancer metastasis. Nat Rev Genet, 8, 341-52.
- Nyante SJ, Devries S, Chen YY, et al (2004). Array-based comparative genomic hybridization of ductal carcinoma in situ and synchronous invasive lobular cancer. Hum Pathol, 35, 759-63. https://doi.org/10.1016/j.humpath.2003.11.009
- Olsson N, Carlsson P, James P, et al (2013). Grading breast cancer tissues using molecular portraits. Mol Cell Proteomics, 12, 3612-23. https://doi.org/10.1074/mcp.M113.030379
- Ostvold AC, Norum JH, Mathiesen S, et al (2001). Molecular cloning of a mammalian nuclear phosphoprotein NUCKS, which serves as a substrate for Cdk1 in vivo. Eur J Biochem, 268, 2430-40. https://doi.org/10.1046/j.1432-1327.2001.02120.x
- Parker ED, Folsom AR (2003). Intentional weight loss and incidence of obesity-related cancers: the Iowa Women's Health Study. Int J Obes Relat Metab Disord, 27, 1447-52. https://doi.org/10.1038/sj.ijo.0802437
- Parkin DM, Fernandez LM (2006). Use of statistics to assess the global burden of breast cancer. Breast J, 12, 70-80. https://doi.org/10.1111/j.1075-122X.2006.00205.x
- Robbins P, Pinder S, de Klerk N, et al (1995). Histological grading of breast carcinomas: a study of interobserver agreement. Hum Pathol, 26, 873-9. https://doi.org/10.1016/0046-8177(95)90010-1
- Roy R, Wewer UM, Zurakowski D, et al (2004). ADAM 12 cleaves extracellular matrix proteins and correlates with cancer status and stage. J Biol Chem, 279, 51323-30. https://doi.org/10.1074/jbc.M409565200
- Salgado R, Benoy I, Weytjens R, et al (2002). Arterio-venous gradients of IL-6, plasma and serum VEGF and D-dimers in human cancer. Br J Cancer, 87, 1437-44. https://doi.org/10.1038/sj.bjc.6600655
- Sargent LM, Ensell MX, Ostvold AC, et al (2008). Chromosomal changes in high- and low-invasive mouse lung adenocarcinoma cell strains derived from early passage mouse lung adenocarcinoma cell strains. Toxicol Appl Pharmacol, 233, 81-91. https://doi.org/10.1016/j.taap.2008.01.031
- Sharabiani MT, Vermeulen R, Scoccianti C, et al (2011). Immunologic profile of excessive body weight. Biomarkers, 16, 243-51. https://doi.org/10.3109/1354750X.2010.547948
-
Silswal N, Singh AK, Aruna B, et al (2005). Human resistin stimulate the pro-inflammatory cytokines TNF-
$\alpha$ and IL-12 in macrophages by NF-$\kappa{B}$ -dependent pathway. Biochem Biophys Res Commun, 334, 1092-101. https://doi.org/10.1016/j.bbrc.2005.06.202 - Smyth MJ, Cretney E, Kershaw MH, et al (2004). Cytokines in cancer immunity and immunotherapy. Immunol Rev, 202, 275-93. https://doi.org/10.1111/j.0105-2896.2004.00199.x
- Strissel KJ, DeFuria J, Shaul ME, et al (2010). T-cell recruitment and Th1 polarization in adipose tissue during diet-induced obesity in C57BL/6 mice. Obesity (Silver Spring), 18, 1918-25. https://doi.org/10.1038/oby.2010.1
- Suarez-Alvarez K, Solis-Lozano L, Leon-Cabrera S, et al (2013). Serum IL-12 is increased in Mexican obese subjects and associated with low-grade inflammation and obesity-related parameters. Mediators Inflamm, 2013, 967067.
- Surendar J, Mohan V, Rao MM, et al (2011). Increased levels of both Th1 and Th2 cytokines in subjects with metabolic syndrome (CURES-103). Diabetes Technol Ther, 13, 477-82. https://doi.org/10.1089/dia.2010.0178
- Trinchieri G (2003). Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol, 3, 133-46. https://doi.org/10.1038/nri1001
- Wang Y, Lam KS, Kraegen EW, et al (2007). Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans. Clin Chem, 53, 34-41.
- Wiese C, Dray E, Groesser T, et al (2007). Promotion of homologous recombination and genomic stability by RAD51AP1 via RAD51 recombinase enhancement. Mol Cell, 28, 482-90. https://doi.org/10.1016/j.molcel.2007.08.027
- Wisniewski JR, Zougman A, Kruger S, et al (2008). Constitutive and dynamic phosphorylation and acetylation sites on NUCKS, a hypermodified nuclear protein, studied by quantitative proteomics. Proteins, 73, 710-8. https://doi.org/10.1002/prot.22104
- Wu HP, Kuo SF, Wu SY et al (2010). High interleukin-12 production from stimulated peripheral blood mononuclear cells of type 2 diabetes patients. Cytokine, 51, 298-304. https://doi.org/10.1016/j.cyto.2010.06.014
- Xiaohong L, Yun W, Ralph BA (2011). Relationships of lipocalin 2 with breast tumorigenesis and metastasis. J Cell Physiol, 226, 309-14. https://doi.org/10.1002/jcp.22403
- Xu J, Chen Y, Olopade OI (2010). MYC and Breast Cancer. Genes Cancer, 1, 629-40. https://doi.org/10.1177/1947601910378691
- Yang J, Bielenberg DR, Rodig SJ, et al (2009). Lipocalin 2 promotes breast cancer progression. Proc Natl Acad Sci USA, 106, 3913-8. https://doi.org/10.1073/pnas.0810617106
- Yang J, McNeish B, Butterfield C, et al (2013). Lipocalin 2 is a novel regulator of angiogenesis in human breast cancer. FASEB J, 27, 45-50. https://doi.org/10.1096/fj.12-211730
- Zavala G, Long KZ, Garcia OP, et al (2012). Specific micronutrient concentrations are associated with inflammatory cytokines in a rural population of Mexican women with a high prevalence of obesity. Br J Nutr, 29, 1-9.
피인용 문헌
- Influence of Propofol, Isoflurane and Enflurance on Levels of Serum Interleukin-8 and Interleukin-10 in Cancer Patients vol.15, pp.16, 2014, https://doi.org/10.7314/APJCP.2014.15.16.6703
- Association of periodontal disease with oral cancer: a meta-analysis vol.35, pp.7, 2014, https://doi.org/10.1007/s13277-014-1951-8
- Circadian gene variants in cancer vol.46, pp.4, 2014, https://doi.org/10.3109/07853890.2014.914808
- NUCKS: a potential biomarker in cancer and metabolic disease vol.128, pp.10, 2015, https://doi.org/10.1042/CS20140656
- Roles of NUCKS1 in Diseases: Susceptibility, Potential Biomarker, and Regulatory Mechanisms vol.2018, pp.2314-6141, 2018, https://doi.org/10.1155/2018/7969068